Morgan Stanley’s iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN SGG Stock Holding History

Morgan Stanley’s Portfolio SGG Stock Details SGG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-220	Closed	-$13.9K	–	8041
2022 Q4	$13.9K	Hold	220	–	–	﹤0.01%	6820
2022 Q3	$12K	Hold	220	–	–	﹤0.01%	7029
2022 Q2	$12K	Hold	220	–	–	﹤0.01%	7174
2022 Q1	$13K	Hold	220	–	–	﹤0.01%	7336
2021 Q4	$12K	Hold	220	–	–	﹤0.01%	7433
2021 Q3	$13K	Hold	220	–	–	﹤0.01%	7262
2021 Q2	$12K	Buy	+220	New	+$11.6K	﹤0.01%	7200

Other funds holding SGG

CWP

Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's SGG Position: Q1 2023 in Review

Morgan Stanley sold out of iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN (SGG) in Q1 2023, closing a stake of 220 shares — an estimated $13.9K sold.

Morgan Stanley first reported a position in SGG in Q2 2021 and held it in 7 quarters. The position peaked at $13.9K in Q4 2022. 4 funds tracked by Wall St. Rank hold SGG as of Q1 2023.

Morgan Stanley reported no remaining iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 220 iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN shares in Q1 2023, an estimated $13.9K.
Morgan Stanley first reported a position in iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN in Q2 2021 and held it in 7 quarters.
Morgan Stanley's iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN position peaked at $13.9K in Q4 2022.
4 funds tracked by Wall St. Rank held iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.